Treatment.com AI Provides an Update on the Status of Exercised Warrants
~800,000 warrants exercised since free trading was announced raising close to half a million dollars. Remaining warrants could bring over $2 million in additional funds. Robust acquisition pipeline VANCOUVER, British Columbia, July 24th, 2024 – Treatment.com AI Inc. (CSE: TRUE, OTC: TREIF, Frankfurt: 939) (the “Company” or “Treatment”), a healthcare tech company transforming patient […]
Treatment.com AI Provides Latest Corporate Update
Positive Financial Update New Partnerships Announced – aiXplain/Novus Health GLM – AI Accuracy and Effectiveness in Healthcare Bolstering the Executive, Scientific and Development Team – Dr. Jean Challiner AI Patient and AI Doctor in Your Pocket planned release in H2 VANCOUVER, British Columbia, July 9th, 2024 – Treatment.com AI Inc. (CSE: TRUE, OTC: TREIF, […]
Treatment.com AI Engages IR Service Provider
VANCOUVER, British Columbia, July 2, 2024 – Treatment.com AI Inc. (CSE: TRUE, OTC: TREIF, Frankfurt: 939) (“Treatment”) has engaged Leit Media Ltd. (“Leit”) of London, UK, to provide investor relations and marketing services with a focus on the German stock market and the German-speaking investor community for an initial period of six months commencing July […]
Treatment.com AI and Novus Health Partnership Expands Access to its Global Library of Medicine (GLM)
VANCOUVER, British Columbia, May 15, 2024 – Treatment.com AI Inc. (CSE: TRUE, OTC: TREIF, Frankfurt: 939) (“Treatment”) is pleased to announce it has signed a Collaborative Agreement with Health Care Services International Inc (o/a Novus Health). (“Novus Health”) to explore utilization of Treatment’s proprietary Global Library of Medicine (“GLM”) to further enhance Novus Health’s Health […]
Treatment.com AI Announces Appointment of Richard Atkins as Chief Operating Officer and Executive Team member
VANCOUVER, British Columbia, May 8th, 2024 – Treatment.com AI Inc. (CSE: TRUE, OTC: TREIF, Frankfurt: 939) (the “Company” or “Treatment”), a healthcare tech company transforming patient care with AI-driven clinical insights is pleased to announce the appointment of Richard Atkins as Chief Operating Officer and a member of the executive team. Mr. Atkins brings to […]
Medical School Renews Contract with Tech Co.
This move further validates the firm’s Medical Education Suite. Discover why one analyst rates this healthcare-disrupting company as a Strong Buy. A leading U.S. medical school renewed its contract to use Treatment.com AI Inc.’s (TRUE:CSE; TREIF:OTCMKTS;939:FRA) Medical Education Suite (MES), the company announced in a news release. MES provides case-based clinical decision-making, testing, grading, and remedial action support to […]
Treatment.com AI Announces Contract Renewal with Leading US Medical School
VANCOUVER, British Columbia, May 1st, 2024 – Treatment.com AI Inc. (CSE: TRUE, OTC: TREIF, Frankfurt: 939) (the “Company” or “Treatment”) is excited to announce one of the leading US medical schools has agreed to a contract renewal utilizing Treatment’s Medical Education Suite (“MES”). Treatment is also in discussions with a number of other medical and […]
Federal funding could further boost Treatment.com AI’s healthcare initiatives
Treatment is bringing AI to the the next generation of healthcare professionals, supporting medical and nursing schools, who use its Global Library of Medicine to enhance future clinical skills of their students. As a Canadian company using AI to positively disrupt the healthcare sector, Treatment welcomed the recent news of a federal government plan […]
Treatment.com AI announces new additions to its Medical Education Suite (MES)
VANCOUVER, British Columbia, April 17, 2024 – Treatment.com AI Inc. (CSE: TRUE, OTC: TREIF, Frankfurt: 939) (the “Company” or “Treatment”) is excited to announce two new solutions, (1) AI Patient and (2) AI Doctor in a Pocket, to augment its Medical Education Suite (“MES”) designed to educate the next generation of healthcare providers. Treatment’s MES […]
Treatment.com AI partners with aiXplain Inc. to extend access to its Global Library of Medicine (GLM)
VANCOUVER, British Columbia, April 10, 2024 – Treatment.com AI Inc. (CSE: TRUE, OTC: TREIF, Frankfurt: 939) (“Treatment”) is pleased to announce it has signed a Collaborative Agreement with aiXplain, Inc. (“aiXplain”) to enable greater access to Treatment’s proprietary Global Library of Medicine (“GLM”) by contributing to aiXplain’s ever-growing dynamic Artificial Intelligence (AI) marketplace. Treatment has […]